EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

RP-HPLC Method Development and Validation for Simultaneous Determination of Ertugliflozin & Sitagliptin Phosphate in Tablet Dosage Form

Muhammad Tariq, Muhammad Abbas, Muhammad Sohail Anwar, Saqib Jahan, Abdul Mateen, Ali Khan, Fazle Hadi, Halima Sadia, Hafiz Sajid Akbar, Yaseen Salih, Haris Ahmad

FRONTIERS IN CHEMICAL SCIENCES · 15.08.2026 · 7 (2) · 115-128

DOI: 10.52700/fcs.v7i2.146 ↗

Kurz gefasst

Fachartikel in der Zeitschrift FRONTIERS IN CHEMICAL SCIENCES, online erschienen am 15.08.2026. Verfasst von Muhammad Tariq und 10 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The anti-diabetic drugs Ertugliflozin and Sitagliptin phosphate is a newly approved fixeddose combination (FDC) tablet. In this method, a sensitive and simple analytical method was developed and validated to simultaneously determine and quantify anti-diabetic drugsErtugliflozin l-pyroglutamic acid and Sitagliptin phosphate in tablet dosage form, as per ICH guidelines. Different strategies were used for developing an economic HPLC method. The separation was achieved on a standard Thermo, BDS Hypersil, C18 column (4.6 mm X 150mm; 5 µm packing L1). The mobile phase used was phosphoric acid (0.1%) & acetonitrile(60:40 v/v). The temperature was kept at ambient condition. The flow rate of mobile phase remained constant at 1.0 mL/ min while the total run time obtained was 8.0 minutes. Ertugliflozin and Sitagliptin were detected at 215 nm respectively using PDA as a detector. Avolume of 20 µL was injected to optimize chromatographic conditions. Various parameters affecting the separation such as the temperature of the column oven, the ratio of mobile phase, and flow rate was optimized. The chromatograms recorded and measured the peak responses for both standard and sample by using the chromatographic condition. An ICH guideline was used to validate the method. All the obtained responses for different validation tests were within the limits.

Zitieren

APA

Tariq, M., Abbas, M., Anwar, M. S., Jahan, S., Mateen, A., Khan, A., Hadi, F., Sadia, H., Akbar, H. S., Salih, Y., & Ahmad, H. (2026). RP-HPLC Method Development and Validation for Simultaneous Determination of Ertugliflozin & Sitagliptin Phosphate in Tablet Dosage Form. FRONTIERS IN CHEMICAL SCIENCES, 7(2), 115-128. https://doi.org/10.52700/fcs.v7i2.146

Vancouver

Tariq M, Abbas M, Anwar MS, Jahan S, Mateen A, Khan A, et al. RP-HPLC Method Development and Validation for Simultaneous Determination of Ertugliflozin & Sitagliptin Phosphate in Tablet Dosage Form. FRONTIERS IN CHEMICAL SCIENCES. 2026;7(2):115-128. doi:10.52700/fcs.v7i2.146

BibTeX
@article{Tariq2026,
  author = {Tariq, Muhammad and Abbas, Muhammad and Anwar, Muhammad Sohail and Jahan, Saqib and Mateen, Abdul and Khan, Ali and Hadi, Fazle and Sadia, Halima and Akbar, Hafiz Sajid and Salih, Yaseen and Ahmad, Haris},
  title = {RP-HPLC Method Development and Validation for Simultaneous Determination of Ertugliflozin & Sitagliptin Phosphate in Tablet Dosage Form},
  journal = {FRONTIERS IN CHEMICAL SCIENCES},
  year = {2026},
  volume = {7},
  number = {2},
  pages = {115--128},
  doi = {10.52700/fcs.v7i2.146}
}
Kostenlos starten →